Latest Articles

Subject

Clinical/Scientific Notes
Pediatric anti-Hu–associated encephalitis with clinical features of Rasmussen encephalitis
Bhooma R. Aravamuthan, Iván Sánchez Fernández, Jonathan Zurawski, et al.

September 24, 2015
Clinical/Scientific Notes
Incomplete Susac syndrome exacerbated after natalizumab
Lana Zhovtis Ryerson, Ilya Kister, Matija Snuderl, et al.

September 24, 2015
Clinical/Scientific Notes
Plasticity-related gene 5: A novel surface autoantigen in paraneoplastic cerebellar degeneration
Marleen H. van Coevorden-Hameete, Esther de Graaff, Maarten J. Titulaer, et al.

September 24, 2015
Article
Pharmacogenomic study in patients with multiple sclerosisResponders and nonresponders to IFN-β
Marta F. Bustamante, Carlos Morcillo-Suárez, Sunny Malhotra, et al.

September 24, 2015
Editorial
Subtype-specific therapy for autoimmune neuropathies?
Eric Lancaster, Steven S. Scherer

September 24, 2015
Article
Gray matter–related proteins are associated with childhood-onset multiple sclerosis
Vaibhav Singh, E. Daniëlle van Pelt, Marcel P. Stoop, et al.

September 24, 2015
Article
GRIN1 polymorphisms do not affect susceptibility or phenotype in NMDA receptor encephalitis
Gregory S. Day, Harald Prüss, Susanne M. Benseler, et al.

September 24, 2015
Article
Effects of diazoxide in multiple sclerosisA randomized, double-blind phase 2 clinical trial
Pablo Villoslada, Alex Rovira, Xavier Montalban, et al.

September 10, 2015
Article
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins
Luis Querol, Ricard Rojas-García, Jordi Diaz-Manera, et al.

September 03, 2015
Article
Direct MRI detection of impending plaque development in multiple sclerosis
Martina Absinta, Govind Nair, Pascal Sati, et al.

September 03, 2015

Pages